Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tom Gallen

Managing Editor, Europe

Birmingham, UK
Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest From Tom Gallen

People On The Move: Appointments At Orkla, PAGB, Afepadi

A round-up of the latest appointments in Europe's consumer health industry: Orkla Health names BioGaia's Ducellier as its CEO; PAGB makes changes to its board; and Afepadi names Uriach's Gispert as its president.

Europe Business Strategies

Germany's Dermapharm Looks To Future With Arkopharma As 2022 Sales Rise

Dermapharm has high hopes for 2023 as its acquisition of Arkopharma means the firm is now the number-one and number-three player respectively in the French and Spanish supplements markets.

Sales & Earnings Europe

Germany's Schwabe Sets Up JV In Brazil With Local Player Herbarium

Schwabe is looking to take a slice of Brazil's growing herbal medicines market by teaming up with local player Herbarium to launch a new joint venture in 2024.

Deals Business Strategies

People On The Move: Appointments At GSCF, Bayer, Shop Apotheke

A round-up of the latest appointments in the consumer health industry: the Global Self-Care Federation elects J&J's Raghunandanan as its chair; Bayer Consumer Health makes changes to its medical leadership; and Shop Apotheke hires ex-DocMorris CEO to lead company.

Executive Changes Leadership

Firm Touting ACV As Cure-All Says It Can’t Afford Trials To Back Up Claims

When investigated for promoting apple cider vinegar as a treatment for a myriad of ailments, from lowering cholesterol to preventing colds and flu, UK-based Willy's told the country's advertising regulator that trials to substantiate these claims were "prohibitively expensive."

United Kingdom Wellness

EU Authorizes Cholesterol Lowering Health Claim For Supplement After 10 Year Wait

France's Laboratoire Lescuyer can now claim its Limicol botanical extract supplement "reduces blood LDL-cholesterol concentrations" after waiting more than 10 years for approval by the European Commission.

Dietary Supplements Innovation
See All